Patient reporting of antineoplastic therapy-associated adverse events should be used to complement physician reporting. 抗肿瘤药的治疗相关性不良事件的病人报告应当用作医生报告的补充。
In addition, cardiovascular and cerebrovascular cultivated antineoplastic drugs and the future will become the new profit growth point. 此外,公司培育的心脑血管药和抗肿瘤药将成为未来新的利润增长点。